CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.
Eligibility Criteria
Inclusion Criteria: * To be eligible to participate in this registry, an individual must meet all the following criteria: 1. Has been diagnosed with moderate to severe atopic dermatitis by a dermatologist or a qualified dermatology practitioner. 2. Is 12 - 15 years of age at the time of enrollment. 3. Meets one of the following conditions at the time of enrollment: 1. Has started taking a new Enrollment Eligible Medication within 6 months prior to the Enrollment visit. A new medication is a medication that the subject has never taken before. OR 2. Is prescribed a new Enrollment Eligible Medication at the Enrollment visit. A new medication is a medication that the subject has never taken before. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in the registry: <!-- --> 1. Is participating or planning to participate in a blinded clinical trial for an AD drug.